Watch the replay of our Integrated Symposia
#1
The value of diagnostic information for antimicrobial stewardship
📢 SPEAKERS
The impact of multiplex PCR in the management of severe pneumonia
Prof. Jean-François TIMSIT, Hôpital Bichat, Paris, FRANCE
The impact of fast ID/AST in the management of bloodstream infections
Prof. Alexia VERROKEN, Cliniques universitaires Saint Luc, Brussels, BELGIUM
How physicians’ beliefs and concerns impact the way diagnostic information is translated into patient management
Prof. Robert HORNE, University College London, UK
Panel discussion and Q&A
🪑 APPOINTED CHAIRS
ESCMID-appointed Chair: Dr. Jeroen SCHOUTEN, RadboudUMC Intensive Care Unit, NETHERLANDS
bioMérieux-appointed Chair: Prof. Claire ROGER, CHU de Nîmes, FRANCE
#2
The value of the syndromic approach for testing respiratory tract infections at point-of-care
📢 SPEAKERS
The Emergency Department physician point of view
Prof. Alexander ZOUFALY, Gesundheitsverbund Wien Klinik Favoriten, Vienna, AUSTRIA
The lab point of view
Dr. Lennart Jan FRIIS-HANSEN, Bispebjerg Hospital, Copenhagen, DENMARK
Panel discussion and Q&A
🪑 APPOINTED CHAIRS
ESCMID-appointed Chair: Dr. Els WESSELS, Leiden University Medical Center (LUMC), NETHERLANDS
bioMérieux-appointed Chair: Dr. Kay ROY, NHS, UK
BE A GAME CHANGER
MEET US ON THE BOOTH TO DISCOVER OUR LATEST INNOVATIONS ON:
SYNDROMIC MOLECULAR
Put it all together for more answers, faster. That’s the idea behind the syndromic approach to molecular testing with multiplex PCR.
POINT-OF-CARE
Save precious time – even give results during a patient visit – by adding reliable diagnostic testing at the point of care.
ANTIMICROBIAL STEWARDSHIP
The latest innovations for fast and reliable ID & AST are key allies in the fight against antimicrobial resistance.
SEPSIS MANAGEMENT
Every minute counts in sepsis. Rapid diagnosis and appropriate antimicrobial treatment are critical to survival.
LAB EFFICIENCY
Key innovations and optimization strategies combine to make any lab gain greater efficiency to meet today’s productivity challenges.
Booth Highlights
VITEK® MS PRIME
Maximize daily routine workflow with enhanced productivity for faster time to reported results, impacting patient care
VITEK® REVEAL™
Integrate rapid Antimicrobial Susceptibility Testing into bioMérieux’s Sepsis Solution to help you better manage bloodstream infections
BIOFIRE® SPOTFIRE® Solution
Offer rapid and comprehensive results at the point-of-care to potentially reduce the need for follow-up appointments, swabbing, and testing.
MAESTRIA™ MIDDLEWARE
Gain a real-time overview of bioMérieux instruments and turn data into actionable insights along with customizable, easy-to-generate reports
BIOFIRE® FILMARRAY® TORCH
Reduce time to optimal therapy, shorten patient stay and avoid unnecessary testing with multiplex PCR using comprehensive panels for syndromic testing
WASPLab®/PhenoMATRIX®
Flexible automated specimen processing and reading with modules to optimize your workflow, including PhenoMATRIX® expert module with advanced artificial intelligence
Product availability varies by country
Scientific Posters & Oral Presentations
Check out bioMérieux’s scientific posters and presentations at ECCMID
| Title | Authors | N° poster | Date | Session name | Session start | Session end | Location | BMX Product or field of interest |
|---|---|---|---|---|---|---|---|---|
| Molecular Biology | ||||||||
| Use of Biofire BCID2 panel in the management of sepsis in a context of controlled prescription | Naouale MAATAOUI et al., France | P1636 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE BCID panel |
| Clinical impact of syndromic molecular Point-of-Care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial | Nathan BRENDISH et al., United Kingdom | E0481 | 16-avr | 7. Parasitic diseases & global health, Intestinal pathogens: old problems, new challenges | 09:30 | 10:30 | Arena 4 | BIOFIRE GI panel |
| Clinical evaluation of the BioFire FilmArray gastrointestinal panel for detection of pathogens associated with gastroenteritis | Yu Hsuan LIU et al., Taiwan, Republic Of China | P1778 | 16-avr | 4e. Strain typing and surveillance (incl. molecular, genomic and other advanced methods) | 12:00 | 13:30 | Poster area | BIOFIRE GI panel |
| Multicentre evaluation of rapid molecular syndromic approach in joint infections using a new dedicated panel | Tiphaine ROUSSEL-GAILLARD et al., France | P1646 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| Cost impact of using a molecular detection panel for managing patients with joint infection | Joan-Miquel BALADA-LLASAT et al., US | P1653 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| An evaluation of a commercial multiplex PCR panel for the diagnosis of joint infections | Pauline KETT et al., Ireland | P1639 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| The role of a commercial joint infection panel in single positive and unexpected negative cultures associated with periprosthetic hip and knee joint infections | S. Gardete-Hartmann et al., Austria | P1754 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| Evaluation of Filmarray® joint infection panel in microbiological diagnosis of acute osteoarticular infections, preliminary results in a chilean cohort | Dona BENADOF et al., Chile | P1721 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| Clinical and microbiological evaluation of the novel syndromic panel for the diagnosis of native and prosthetic joint infections, a pilot study | Mitja RAK et al., Slovenia | P1680 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE JI panel |
| Evaluation of a new rapid syndromic multiplex PCR panel for the diagnosis of patients with a suspicion of joint infection in a real world environment | Stéphanie PASCUAL et al., France | O0871 | 17-avr | 4. Diagnostic microbiology. Bone and prosthetic joint infections: addressing diagnostic challenges | 11:00 | 12:00 | Hall M | BIOFIRE JI panel |
| High prevalence of inherited chromosomally integrated human herpes virus type 6 (ici-HHV6) detected in cerebral spinal fluid from children with HHV6 detection by a meningitis/encephalitis multiplex panel | Huanyu WANG et al., US | O0147 | 15-avr | 1. Viral infection & disease. Diagnostic, therapeutic and prophylactic strategies in herpesviruses infections | 11:00 | 12:00 | Hall M | BIOFIRE ME panel |
| Prospective evaluation of the BioFire FilmArray Meningitis/Encephalitis Panel performance in hospitalised infants | Beata KASZTELEWICZ et al., Poland | P1728 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE ME panel |
| Cost evaluation of the INHALE trial: investigating the cost implications of rapid molecular diagnostics in the ICU for managing nosocomial pneumonia in UK intensive care units (ICU) | Virve ENNE et al., United Kingdom | P1710 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE PN panel |
| ICU clinicians' perceptions of rapid multiplex PCR for diagnosis of pneumonia and barriers to application in practice: an INHALE trial sub-study | Sarah-Jane STEWART et al., United Kingdom | P1701 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE PN panel |
| Randomized trial measuring the clinical impact of the FilmArray® Pneumonia panel plus in critically ill | Alexia VERROKEN et al., Belgium | P1698 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 12:00 | 13:30 | Poster area | BIOFIRE PN panel |
| The clinical impact of syndromic point-of-care PCR testing on antibiotic treatment of patients admitted with suspected community-acquired pneumonia in emergency departments: a multi-centre randomised controlled trial | Mariana CARTULIARES et al., Denmark | O0867 | 17-avr | 2. Bacterial infection & disease;Cutting edge in respiratory bacterial infections | 11:00 | 12:00 | Hall I | BIOFIRE PN panel |
| The feasibility of implementing a close to patient molecular test to determine the aetiology of non-ventilator acquired hospital acquired pneumonia (NV-HAP) | Joseph WOOD et al., UK | E0948 | 17-avr | 4. Diagnostic microbiology, New diagnostic tools for respiratory infections | 13:30 | 14:30 | Arena 3 | BIOFIRE PN panel |
| Microbiology of of hospital-acquired and ventilator-associated pneumonia as detected by multiplex PCR in intensive care unit patients from the UK: an INHALE sub-study | Zaneeta DHESI et al., UK | E0951 | 17-avr | 4. Diagnostic microbiology, New diagnostic tools for respiratory infections | 13:30 | 14:30 | Arena 3 | BIOFIRE PN panel |
| Impact of rapid multiplex PCR on the antimicrobial therapy management in VA-LTRI patients: an observational study | Andrea Palomeque et al., Spain | O1045 | 17-avr | 4. Diagnostic microbiology, Do we trust the results of new diagnostic technologies for the treatment of respiratory infections? | 16:15 | 18:15 | Hall P | BIOFIRE PN panel |
| INHALE WP3: Clinical outcomes and antimicrobial stewardship analyses from of a multi-centre RCT (INHALE) testing the utility of rapid multiplex PCR for hospital-acquired and ventilator-associated pneumonia in critical care | Virve ENNE et al., UK | O1041 | 17-avr | 4. Diagnostic microbiology, Do we trust the results of new diagnostic technologies for the treatment of respiratory infections? | 16:15 | 18:15 | Hall P | BIOFIRE PN panel |
| Multiplex PCR pneumonia panel for microbiological diagnosis and the clinicians' perspective on the utilisation of the results in the management of patients with LRTI: a one-year experience in a private tertiary care centre | Fong SI WEI et al., Malaysia | O1043 | 17-avr | 4. Diagnostic microbiology, Do we trust the results of new diagnostic technologies for the treatment of respiratory infections? | 16:15 | 18:15 | Hall P | BIOFIRE PN panel |
| Impact of the Biofire Filmarray Pneumonia Panel to guide exacerbations diagnostic and treatment in bronchiectasis | Laia FERNáNDEZ-BARAT et al., Spain | O1044 | 17-avr | 4. Diagnostic microbiology, Do we trust the results of new diagnostic technologies for the treatment of respiratory infections? | 16:15 | 18:15 | Hall P | BIOFIRE PN panel |
| Procalcitonin combined to point of care molecular respiratory panel testing for antibiotic stewardship in the emergency room : the PROARRAY study | Pierre HAUSFATER et al., France | P2315 | 17-avr. | 5d. Antimicrobial stewardship and prescribing (incl. interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects) | 12:00 | 13:30 | Poster area | BIOFIRE RP panel |
| Performance of a new rapid syndromic respiratory and sore throat panel with external quality assessment programmes | Monica CRONIN et al., United States | P1678 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 09:30 | 10:30 | Arena 4 | SPOTFIRE R/ST |
| Evaluation of a rapid multiplex PCR diagnostic device for the detection of microorganisms from nasopharyngeal and throat swab specimens in the near patient setting | Jeffrey BASTAR et al., United States | P1739 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 09:30 | 10:30 | Arena 4 | SPOTFIRE R/ST |
| Analytical Performance of the BioFire SpotFire Respiratory/Sore Throat (R/ST) Panel and BioFire SpotFire System | Heidi BUTZ et al., United States | P1706 | 16-avr | 4d. Molecular diagnostics (incl. POCT and syndromic testing) | 09:30 | 10:30 | Arena 4 | SPOTFIRE R/ST |
| Clinical agreement study between COVID-19 R-GENE® real-time PCR assay and Allplex SARS-CoV-2 assay on nasopharyngeal swab and saliva paired samples, broncho-alveolar lavages, nasal aspirates, nasal swabs and oropharyngeal swabs | Agata Scalcione et al., Italy | P2593 | 17-avr | 12d. Diagnostics (incl. molecular, genomic, rapid tests) | 12:00 | 13:30 | Poster area | Covid-19 R-gene |
| Microbiology | ||||||||
| Rapid and reliable identification of microorganisms from early growth of positive bloodcultures using MALDI-TOF mass spectrometry | Melanie Yarbrough, Kelly Alvarado, Brittany Roemmich | 1614 | 16-avr | 4c. MALTI-TOF and other proteomic methods | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Evaluation of a new Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectrometry instrument in a high throughput routine laboratory | Maria Raptaki, Melanie Piaschinski, Simone Feldmeier, Anja Flagmeier, Janhendrik Timm, Yoann Crase, Sebastian Grund | 1621 | 16-avr | 4c. MALTI-TOF and other proteomic methods | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Performance of two new MALDI-ToF systems for identification of common and rare yeasts | S. Graeber, P. Thelen, E. Schmidt , S. Göttig, G. Walthe, O. Kurzai, A. Hamprecht | 1623 | 16-avr | 4c. MALTI-TOF and other proteomic methods | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Performance of two MALDI-TOF MS systems for the identification of filamentous fungi including a new, easy, fast and reliable workflow | S. Graeber, P. Thelen, A. Hamprecht | 1616 | 16-avr | 4c. MALTI-TOF and other proteomic methods | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Analysis of the performance of two new MALDI-TOF systems | P. Thelen, S. Graeber, A. Hamprecht | 1612 | 16-avr | 4c. MALTI-TOF and other proteomic methods | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Enhancing positive blood culture workflows by combining lab automation and streamlined processes: an example of VITEK MS PRIME integration optimized by application of lean principles | Olivier Duquesnoy, et al. France | 1605 | 16-avr | 4b. Laboratory management | 12h00 | 13h30 | Poster area | VITEK MS PRIME |
| Whole genome analysis of Gram-negatives using the EPISEQ-CS platform and other bioinformatics platforms | Elvira Garza-Gonzalez, et al. | 299 | 15-avr | 3b. Resistance surveillance & epidemiology: Gram-negatives | 12h00 | 13h30 | Poster area | EPISEQ-CS |
| VITEK2 Advanced Expert System β-Lactam Resistance Phenotyping compared to Whole Genome Sequencing in Enterobacterales Isolates from European Medical Centres | Cecilia Carvalhaes, Paul Rhomberg, Nabina Gurung, Nathan Veeder, Mariana Castanheira | 384 | 15-avr | 3c. Susceptibility testing methods | 12h00 | 13h30 | Poster area | VITEK2 AES |
| Performance of VITEK REVEAL system for rapid antimicrobial susceptibility testing of Gram-negative bacteraemia: results from a multicentre study in France | Laurence Parmeland, Delphine Chainier, Alexis Pontvianne, Carole Grelaud , Rudolph Piris, Richard Remington, Catherine Ott, Yohann Bala, Mathieu Pecquet, Richard Bonnet, Olivier Barraud | 343 | 15-avr | 3c. Susceptibility testing methods | 12h00 | 13h30 | Poster area | VITEK REVEAL (SPECIFIC REVEAL) |
| Evaluation and validation of the specific diagnostics REVEAL rapid antimicrobial sensitivity testing system on antibiotic resistant strains of Escherichia coli and Klebsiella pneumoniae, and Gram-negative blood culture isolates | Rhys Evans, Joanna Diggle, Mandy Wootton | 364 | 15-avr | 3c. Susceptibility testing methods | 12h00 | 13h30 | Poster area | VITEK REVEAL (SPECIFIC REVEAL) |
| Retrospective evaluation of rapid phenotypic AST system on positive blood culture turnaround time and potential impacts on bloodstream infection management | Ismail Yuceel-Timur, Elise Thierry, Delphine Chainier, Ibrahima Ndao, Maud Labrousse, Carole Grelaud, Yohann Bala, Olivier Barraud | 386 | 15-avr | 3c. Susceptibility testing methods | 12h00 | 13h30 | Poster area | VITEK REVEAL (SPECIFIC REVEAL) |
| Rapid antibiotic susceptibility testing on blood cultures positive for gram-negative bacilli : an interventional study, France, 2022 | Nabil Gastli, Martin Belan, Alexandra Doloy, Cécile Guyonnet, Eléanor Din, Caroline Charlier, Claire Poyart, Etienne Canouï, Asmaa Tazi | 2376 | 15-avr | 5d. Antimicrobial stewardship and prescribing | 12h00 | 13h30 | Poster area | VITEK REVEAL (SPECIFIC REVEAL) |
| Whole genome sequencing data of colistin-resistant Enterobacteriaceae intestinal carriage isolates from healthy volunteers: first report from India | Abdul Ghafur et al | 117 | 15-avr | 3b. Resistance surveillance & epidemiology: Gram-negatives | 12h00 | 13h30 | Poster area | CHROMID COLR |
| Solving the puzzle of lab management - The impact of lab assessment on productivity and turnaroud time in a large laboratory in Brazil | Carlos Domingos, Cássia Sant Anna, Juliana Ortega, Bernardo Barros, Monica Gutierrez-Granado, Sandra Vallejo, Antonio Fabron | 1588 | 15-avr | 4b. Laboratory management | 12h00 | 13h30 | Poster area | Lab consultancy |
| Impact of centralized BACT/ALERT Virtuo blood culture system (VIRTUO) implementation on outcomes in patients with Gram-negative bacteremia | Christopher Destache, Dayla Boldt, Jennifer Anthone, Manasa Velagapudi, Richard Swaney, Julie Jerabek, Nicolas Malik, Jassmine Williams, Rutendo Jokomo-Nyakabau, Renuga Vivekanandan, Stephen Cavalieri | 1592 | 15-avr | 4b. Laboratory management | 12h00 | 13h30 | Poster area | BACT/ALERT VIRTUO |
| Accuracy of Vitek susceptibility testing from short-incubation cultures, using a challenge set of Enterobacterales | Jie HE, Singapore | 15-avr | 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) | 12h00 | 13h30 | Poster area | VITEK2 AES | |
Visit us at ECCMID
From April 15-18, 2023, ECCMID is the opportunity to discover innovations from bioMérieux.
We hope to see you there!
🌐 Online
📅 Onsite in Copenhagen, Denmark
📍 Booth #C3-09
